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ABSTRACT
Human cells are, in general, poor recipients of foreign
DNA, which has severely hampered the cloning of
genes by direct phenotypic correction of deficient
human cell lines after DNA mediated gene transfer. In
this communication a methodology is presented which
largely circumvents this problems. The method relies
on the use of a recently developed episomal Epstein -
Barr-virus-derived cDNA expression vector (Belt et al.
(1989) Gene 84, 407-417). The cloning of
hypoxanthine phosphoribosyltransferase (HPRT)
cDNA, corresponding to a low abundant mRNA in wild
type cells Is used as a model system. Size fractionated
poly (A)+ RNA from wild type cells, which resulted in
an approximately 10 fold enrichment in HPRT mRNA,
was used to construct a cDNA library of 25,000
independent clones in the pECV25 vector. An HPRT
deficient human cell line was transfected and
subsequently selected with hygromycin B for DNA
uptake. In a small scale experiment only 7000
hygromycin BR transfectants were sufficient to isolate
2 independent HATR clones which were shown to
replicate episomes harbouring HPRT cDNA. The first
insert had a 5' untranslated region (UTR) and a 3' UTR
perfectly in agreement with published data. The second
cDNA clone harboured an unusually long 5' UTR and
a shorter 3' UTR due to alternative polyadenylation of
the HPRT transcript which has not been previously
recognized.
INTRODUCTION
Cloning of mammalian genes by direct phenotypic correction
through DNA-mediated gene transfer is a difficult and very
laborious task especially in cases where little is known about the
gene or protein of interest and only mutant cell lines of human
origin are available. There are only a very few recent examples
of successful correction of deficient human cell lines by cDNA
or genomic DNA transfections leading to complementation and
cloning of the correcting gene (1-3). Molecular cloning in this
way is hampered by the-in general-poor transfectability and
limited DNA uptake of human cells. It has been demonstrated
that human cells are several orders of magnitude less efficient
in gene cloning experiments than most commonly used rodent
cells. (4-7). To circumvent this problem, a number of research
groups have first generated mutant cell lines of non-human species
(e.g. rodent cell lines, but lower eukaryotes or even bacteria have
been used as well), which have a comparable phenotype to the
human mutant, but are much easier to transfect (8-14 for
examples). After the introduction of human genomic DNA or
cloned cDNA into these cells the gene of interest is isolated and
tested in the human or rodent mutant for complementation.
However, this approach is still very laborious and depends greatly
on the availability of homologous mutants of non-human origin
as well as the evolutionary conservation of the studied genetic
system. Hence, we have looked for a system that should facilitate
cloning of human genes by direct complementation of the human
mutant cell line.
Recently, we developed an EBV-derived cDNA expression
vector with promising features in relation to the problem
described above (15). Our results showed that in the presence
of the EBV (oriP, EBNA-1) sequences: 1.) the transfection
efficiency increases 5-10 times in comparison to vectors lacking
these sequences, 2.) the copynumber is 5-10 fold higher in
human cells and 3.) in a reconstruction experiment the isolation
of a low-abundance sequence from a mixture of vectors is at least
100-fold more efficient then when conventionally used integrating
vector systems are used. These characteristics predicted the
suitability of this vector in cDNA cloning experiments.
In this report we have assessed the efficiency of the EBV vector
system in cloning human cDNA from a library by direct
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phenotypic correction of a mutant human cell line. As a model
system we used human cells deficient in hypoxanthine
phosphoribosyltransferase (HPRT), a defect related to the Lesch-
Nyhan syndrome. Our results suggest that episomal cDNA
expression vectors constitute an efficient tool to isolate genes by
direct complementation of human mutant cell lines.
MATERIALS AND METHODS
Isolation and Fractionation of poly(A)+ RNA
Total RNA was prepared from a human chronic myelogenous
leukemia cell line K562 as described by Auffray and Rougeon
(16). Poly(A)+ RNA was isolated by two passages over oligo
dT cellulose. 400 Itg of poly(A)+ RNA was size-fractionated by
sucrose gradient centrifugation essentially as described by
Legerski et al. (17) with minor modifications.
Microinjection
170LAD primary human fibroblasts from a Lesch-Nyhan patient
(18) were cultured in Ham's F0 medium supplemented with
10% fetal calf serum and antibiotics, (penicillin 100 U/ml and
streptomycin 100 tsg/ml). Microinjection of poly(A)+ RNA
fractions (2tg/jtA RNA dissolved in 1mM Tris-HCl pH 7.5,
0. 1mM EDTA) into Lesch-Nyhan cells was performed as
described by de Jonge et al. (19). After an expression time of
0.5-4 h, cells were cultured in hypoxanthine-free Ham's FIO
medium supplemented with 10% dialyzed fetal calf serum,
antibiotics and 3H-labeled hypoxanthine (5 ACi/ml; specific
activity 6.7 Ci/mmole) for 20 hr. After Bouin fixation the
preparations were processed for autoradiography (Ilford K2
tracking emulsion), exposed for 2-3 days at 4°C, developed
and stained with Giemsa solution.
cDNA library construction and subcloning into pECV25
The poly(A)+ RNA fraction correcting the HPRT- phenotype
to the highest level was used to generate a cDNA library. The
cDNA preparation was carried out essentially as described by
D'Alessio et al.(20). Briefly, 3 ,ug of size-selected poly(A)+
RNA was converted into cDNA using 200 U of murine reverse
transcriptase (Bethesda Research Laboratories) and oligo(dT) as
a primer. After second strand synthesis the cDNA was made
blunt-ended with T4 DNA polymerase. The cDNA was cloned
in the EcoRI site of XZAP (Stratagene) after methylation with
EcoRI-methylase and ligation of EcoRI linkers as previously
described (21). Total DNA was isolated from the XZAP library
using standard techniques (22) and 16 ,g was digested with NotI
and SaiI for subcloning of the cDNA into the pECV25 vector
(15, see figure 2). 4 yg of pECV25 plasmid DNA was digested
with NotI, XoI and PvulI (to destroy the AGPT gene) and added
to the NotI + Sall digested cDNA (molar ratio vector:cDNA
1:1). Ligation was performed in a reaction volume of 250 ,tl with
50 U of T4 ligase (Pharmacia) for 16h at 14°C. The ligation
mixture was used for transformation of E. coli strain MH1 (23).
Transfection and Isolation of HATR Clones
SV40-transformed XP12ROH- cells (an HPRT deficient mutant
originated after 6-Thioguanine selection from an
SV40-transformed primary fibroblast line of a xeroderma
pigmentosum patient) were cultured in DMEM/F1O (1:1)
supplemented with 10% fetal calf serum, penicillin and
streptomycin. Transfection was performed as described earlier
(15). Hygromycin B selection (75 ,ug/ml) was started 48 hr after
Figure 1. A. Sucrose gradient centrifugation of total poly(A) RNA from K562
cells. Samples of collected fractions were loaded on a 1.2% agarose gel and stained
with ethidium bromide after electophoresis. M 1: Ribosomal RNA markers. After
microinjection of several fractions into Lesch-Nyhan cells screening was done
for incorporation of tritium-labeled hypoxanthine. Results are indicated at the
top panel. (n.d. = not done). B. Micrograph of an HPRT deficient 170LAD
primary fibroblast of a Lesch-Nyhan patient, microinjected with size-fractionated
poly(A)+ RNA from K562 cells (fraction no. 12, fig. IA) incubated in the
presence of 3H labeled hypoxanthine and processed for autoradiography.
Autoradiographic grains indicate incorporation of 3H labeled guanine into RNA.
1) Injected cell. 2) Non-injected cell.
transfection and continued for 11 days. Then HAT selection (24)
was performed. HAT resistant clones were isolated and grown
under continuous HAT selection pressure.
Low Molecular Weight DNA isolation and sequencing
LMW DNA isolation was carried out as previously described
(15). Isolated material was introduced into Escherichia coli strain
MC1061 (23) by electroporation as detailed by Dower et al. (25)
using a Biorad Gene Pulser set at 25 ,F and 2.5 kV, and a Pulse
Controller (Biorad) set at 200 Q.
For sequencing of the 5' and 3' end of the isolated HPRT
cDNA's, the inserts were subcloned into the EcoRI site of pUC19
(26). Double strand sequencing was performed with ct-35S-
dATPS and T7 DNA polymerase (Pharmacia) according to the
procedure specified by the enzyme supplier.
RESULTS
Generation of a cDNA library enriched in HPRT cDNA
sequences
As a first step in the isolation of hypoxanthine phosphoribosyl-
transferase (HPRT) cDNA, K562 poly(A) + RNA was enriched
in mRNA coding for HPRT through size-selection by sucrose-
gradient centrifugation. Fractions were collected, microinjected
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Figure 2. Subcloning ofcDNA from the XZAP vector into the EBV-derived cDNA
expression vector pECV25. Abbreviations: agpt: aminoglycoside
3'phosphotransferase gene conferring resistance to G418; ApR: E. coli f3-
lactamase gene conferring resistance to ampicillin; E: EcoRI site; EBNA-1:
Epstein-Barr virus nuclear antigen 1; hph: hygromycin B phosphotransferase
gene conferring resistance to hygromycin B; oriP: Epstein-Barr virus origin
of replication; N: Notl site; P: PvuIl site; polyA: rabbit f3-globin polyadenylation
site; splice: rabbit ,B-globin second intron; X: XhoI site; Open arrow: RSV-LTR;
Black arrow: HSV- I tk promoter region.
into 170LAD Lesch-Nyhan primary fibroblasts (HPRT deficient)
and screened for the incorporation of tritium-labeled hypoxanthine
(fig. 1). Fraction no. 12 with an approximate size of 1300-1400
b. on average was chosen for the preparation of a cDNA library
in XZAP. This library, which had an original complexity of
25,000 independent clones and contains cDNA inserts in two
possible orientations, was subcloned into the EBV-derived cDNA
expression vector pECV25 (fig. 2) as described in MATERIALS
and METHODS. Here approximately 200,000 independent ApR
clones were generated. The pECVZAP1 library was used for
transfection experiments with the HPRT deficient cell line
XP12ROH- as a recipient. A schematic representation of the
transfection and selection strategy is shown in figure 3.
Transfection of pECVZAP1 cDNA library to HPRT- cells
18 dishes of XP12ROH- cells (1 x 106 cells/dish) were
transfected with 10 itg of pECVZAPl per dish. As a control,
each of 6 dishes of cells was transfected with 10 Atg of pECV25
vector DNA. After 11 days of hygromycin B selection (75lsg/ml)
approximately 400 hyg BR clones per dish were obtained from
cells transfected with the library (transfection frequency:
4 x 10-4), whereas 700 hyg BR clones appeared on the control
dishes (transfection frequency: 7 x 10-4). The apparent lower
transfection efficiency with pECVZAPI may be due at least in
part to overexpression of either sense or antisense orientated
cDNA sequences that interfere with cell proliferation.
The hyg BR clones were subsequently grown in HAT
selection medium. One week later 3 HATR clones became
visible on 3 separate dishes. 16 days after starting HAT selection
2 clones could be isolated and grown to mass culture. Clone no.
1 did not survive the isolation and the subsequent selection
procedure. During growth of the remaining two clones we had
some difficulties in passaging cells, especially from clone no.
Figure 3. Scheme of the HPRT cDNA cloning procedure. (for further explanation
see text.)
Table 1. Efficiencies of the pCD system (33) and the pECV system (this study)
in the generation of HATR clones.
cDNA Recipient Number of Number of Number
library cell line transfected transfectants HATR
cells clones
pCD-GM637 A9 (mouse) 107 105 (G418R) 3
pECVZAPI XP12ROH- (human) 1.8x 107 7x103 (hyg BR) 3
2. This is probably due to accumulation of a population of cells
loosing the HPRT cDNA but surviving selection by cross-feeding
(metabolic cooperation) from cells still maintaining vectors with
a HPRT insert. (27). To specifically enrich for the HPRT cDNA
among other cDNA's within the HATR clone (one cell can
replicate up to 50 different episomes, see 15), growth under HAT
selection was continued for another 2 months. The rationale of
such an approach is based on the fact that 2-5% of the cells
per generation loose vector DNA in the absence of selecting agent
(28). Thus when the specific selection is continued long enough
one can expect to end up with cells harbouring a plasmid
population enriched in the cDNA of interest. We have shown
previously in reconstruction experiments that this is indeed the
case (15).
After two months of growing cells in HAT medium, plasmid
material was rescued from both clones by low molecular weight
extraction (see fig. 4). From clone no. 3 a total of 43 plasmids
was rescued. Restriction analysis revealed that these 43 plasmids
consisted of two classes of plasmids: one class represented by
pECVH3-1 (33 out of 43) had an insert of approximately 750 bp.
whereas the insert of the other class of plasmids (10 out of 43)
represented by pECVH3-2 had a length of approximately 1350
bp.
From the other HATR clone no. 2 initially only two plasmids
could be rescued. pECVH2-1 was deleted and contained only
sequences for EBNA-1, ampicillin resistance, ori of pBR322 and
the element oriP. Plasmid pECVH2-2 consisted of a tandem
repeat of 3 vector copies (one incomplete copy) with 3 different
cDNA inserts of approximately 700 bp., 1150 bp. and 1350 bp.
(see fig. 4). To check which of these 4 classes of plasmids were
pECV25 E
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Figure 4. Plasmid DNA rescued from HATR clone 2 and 3. A. Schematic representation of plasmids pECVH3-1 and pECVH3-2 from clone 3 (no. 2 and 3) and
of plasmids pECVH2-1 and pECVH2-2 from clone 2 (no. 4 and 5) as compared to pECV25 (no. 1). Results of the individual transfection of these plasmids into
XP12ROH- cells are indicated on the right. B. EcoRI digest of rescued plasmids loaded on a 1% agarose gel, stained with ethidium bromide after electrophoresis.
Numbers are as described under A. Note the complex structure of pECVH2-2 as indicated by the different intensities of the digested bands on the gel. Abbreviations
as in figure 2. S: Sall site; M: Phage X DNA digested with EcoRI and HindIII; a-e: different cDNA inserts.
responsible for correcting the HPRT- phenotype, the rescued
plasmids were introduced individually into XP12ROH- cells.
First hygromycin B selection and then HAT selection was
performed. Transfection of pECVH2-2 and pECVH3-2 resulted
in the generation of HATR clones with a high efficiency,
whereas transfection of pECVH2-1 and pECVH3-1 as well as
the pECV25 control plasmid did not correct the HPRT-
phenotype.
Analysis of the cDNA inserts of plasmids correcting the
HPRT- phenotype
The 5' and 3' end of the HPRT cDNA insert from pECVH3-2
were sequenced and compared to the published HPRT cDNA
sequence (29). Results are shown in figure 5. The 5' end was
only 7 bp. shorter then the cDNA cloned by Jolly et al. (29) and
no difference was observed at the 3' end of the cDNA. Since
the structure of pECVH2-2 was more complicated (see above),
we used pECVH3-2 as a probe and showed that the insert of
approximately 1150 bp. harboured the HPRT cDNA. That this
insert is indeed responsible for the acquired HATR phenotype
is further substantiated by the following observation: A rescue
of plasmid DNA from clone no. 2 performed after one extra
month of culturing cells in HAT selective medium resulted in
another 8 plasmids, all rearranged but originating from
pECVH2-2. Out of 8 plasmids, 6 harboured the HPRT insert
of 1150 bp. (data not shown). After subcloning the 1150 bp.
cDNA insert into pUC19 the 5' and 3' end were sequenced.
Comparison with the published sequence of Jolly et al. revealed
that at the 5' end the 1150 bp. cDNA is 44 bp. longer, which
results in a 5'-untranslated region of 129 bp. This feature is in
agreement with the reported heterogenous set of transcription
initiation sites for HPRT, mapped in this region aswell (30, 31).
At the 3' end the pECVH2-2 cDNA is 322 bp. shorter as
compared to the published sequence. Our results suggest that this
shorter mRNA is the result of alternative polyadenylation. Indeed
an additional polyadenylation signal AATAAA is present in
HPRT and localized 21 bp. upstream of the poly(A) tail of the
1150 bp. cDNA (figure 5). These results are the first indications
of differential polyadenylation of HPRT mRNA in human cells.
Alternative polyadenylation of HPRT has also been observed in
hamster cells (32), but at a different position compared to its
human homolog.
DISCUSSION
In our previous work (15) an episomal (Epstein-Barr-virus-
derived) cDNA expression vector was compared with
conventional integrating vectors for several molecular genetic
applications. A number of advantages of the episomal vector
system were found. A higher transfection efficiency of human
cells, a higher copynumber and the episomal state of the vector
resulted in a 100 fold increase in the efficiency of isolating
underrepresented inserts from a large mixture of vectors with
different inserts. Therebye, selected episomes could easily be
rescued from isolated human cell clones.
This communication shows that the same episomal vector
system can be efficiently utilized in cDNA cloning. The isolation
of 2 functional cDNA clones by direct correction of a human
genetic defect in cultured cells in a small scale transfection
experiment is presented. HPRT deficiency was used as a model
system because many human mutant cell lines, either originating
from patients with the Lesch-Nyhan syndrome or derived
experimentally from cell lines, are available and efficient selection
for a corrected HPRT+ phenotype is possible in cell culture
(24). Furthermore HPRT is a low abundant mRNA in wild type
cells (2-5 mRNA copies per cell, 29). The procedure described
here is highly efficient. Indeed, from 18 dishes (106 recipient
cells per dish) transfected with the pECVZAPI library (initial
complexity 25,000 cDNA inserts cloned in two orientations), 3
independent HATR clones were obtained. In table 1 a
comparison is made between the results obtained here and those
obtained in the experiments of Okayama and Berg (33) who have
isolated HATR clones after transfection of mouse L cells with
the XNMT-pCD library (an expression library with cDNA
inserted in an oriented fashion in the SV40-based pCD vector,
which subsequently is incorporated in a bacteriophage lambda
I.
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5' UTR
A TCTTGCTGCGCCTCCGCCTCCTCCTCTGCTCCGCCA
-80 -70 -60 -50
B CGAGCCCTCAGGCGAACCTCTCGGCTTTCCCGCGCGGCGCCGCCTCTTGCTGCGCCTCCGCCTCCTCCTCTGCTCCGCCA
-120 -110 -100 -90 -80 -70 -60 -50
C
=/== ATG
=/== ATG
GCGCCTCCGCCTCCTCCTCTGCTCCGCCA = =/ ATG
-70 -60 -50 1
3' UTR
A TAA / AATAAA == / AAATAAATTCCCAAAAATTTAn
657 960 1230 1240
B TAA / AATAAAGAGAAGATATATTAGTTTTTTA,
657 960 970 980
C TAA /= ==== AATAAA ================ AAATAAATTCCCAAAAATTTA,
657 960 1230 1240
Figure 5. Sequences of the 5' and 3' untranslated region of the isolated HPRT cDNA's as compared to the sequence published by Jolly et al. (29). Polyadenylation
signals responsible for the poly(A) tail are underlined. A. HPRT cDNA sequence reported by Jolly et al. (29); B. HPRT cDNA insert from pECVH2-2; C. HPRT
cDNA insert from pECVH3-2. Numbers indicate the relative distance from the translational start site.
vector for efficient transduction of mammalian cells; the system
is dependent on chromosomal integration for stable expression
of the cDNA). Obviously an absolute comparison of both studies
is not possible, as different experimental protocols were used
including different cDNA libraries, recipient cells and transfection
and selection procedures. However, a juxtaposition of both sets
of data may nevertheless be useful to emphasize the specific
advantages and limitations of each of the two systems. In the
case of the XNMT-pCD experiment the high efficiency of
isolating HATR clones is mainly due to the very high
transfectability of the rodent acceptor cells which have been used
(transfection frequency: 10-2) whereas the frequency of
selecting HATR clones from the pool of transfected cells is
rather low (selection frequency: 3 x l0-5). In the case of the
episomal library transfected to human cells the transfection
efficiency is relatively low (transfection frequency: 3.9x 10-4)
as with many cells of human origin, however, the ability to select
HATR clones from the pool of transfected cells (selection
frequency: 4.3 x 10-4) is clearly increased as compared to the
integrating vector system. Due to this higher selection frequency
the overall efficiencies of both systems are similar, suggesting
that the use of the episomal expression system does compensate
for the low transfectability inherent to the use of human acceptor
cell lines. Of course one has to take into account that a size-
fractionated mRNA population has been used for the construction
of the pECVZAPl library (from figure 1 we estimate an
enrichment of approximately 10 fold in HPRT mRNA).
However, since the cDNA is cloned in two possible orientations
the gain in cloning efficiency obtained by mRNA enrichment is
reduced to half this figure when compared with a total library
cloned in an oriented fashion such as the XNMT-pCD library.
Although the efficiency of the pECV/human system using a
complete cDNA library might be 5-10 times less efficient as
compared to the XNMT-pCD/mouse system, it is still much more
efficient as what is expected by taking into account the differences
in transfection efficiency and DNA uptake between both cell
types. Apparently, the major advantage of using episomal cDNA
expression vectors resides in the fact that most of the 50 episomes
per cell (15) have the same ability to express their specific cDNA
insert efficiently in contrast to conventional vectors where
expression of each insert might be differently influenced by
positional effects due to chromosomal integration.
Another important outcome of the present study is the fact that
the use of an episomal cDNA library does significantly simplify
the rescue of the cDNA clone of interest. In the case of integrating
vector systems diluting-out of integrated vectors which do not
harbour the cDNA of interest can only be performed by secondary
or even tertiary transfections depending on the number of vector
copies per cell originally present in the primary transformant.
Once a transfectant has been obtained which contains only a few
copies of plasmid DNA the cDNA of interest can be rescued by
cosmid cloning or by PCR amplification. It should be clear that
such experiments are very laborious and time consuming. In
contrast, we have shown here that diluting-out of episomes which
do not contain the cDNA insert is easily managed by simply
culturing isolated clones obtained during the primary transfection
procedure, under conditions which select specifically for the
cDNA insert of interest for a period of 1-2 months. This feature
is based on the fact that episomes which are not subjected to
selection pressure are lost from the cells with a frequency of
2-5% per generation (28). The results presented here show that
after a culture period of 2 months only a few different episomes
could be isolated from HATR cells, a number which was small
enough to allow the individual testing of each of the rescued
plasmids.
At this moment we do not understand the nature of the
rearranged plasmids rescued from clone no. 2. As a result of
the ligation procedure during the subcloning of the cDNA into
pECV25 concatamers might have been formed, which are further
rearranged in the recipient cell. On the other hand they might
have arisen in the transfectant itself. Several groups have reported
on rearrangements or even integration of EBV-derived vectors
(34-37). In contrast to our system however, in these cases
repetitive sequences were present in the vector or insert used,
which might have been the cause of the observed rearrangements.
The data presented here show that the presence of rearranged
episomes does not need to be a major disadvantage. Indeed,
despite the rearrangements found in clone no. 2, rescue of
plasmids harbouring full length HPRT cDNA was possible, even
after 3 months of culture.
The cDNA library used in this study had a low original
complexity (25,000) and was cloned in XZAP in two orientations,
reducing the number of cDNA's that are properly expressed to
half this figure. The use of cDNA libraries cloned in expression
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vectors in an oriented manner would certainly further optimize
the system described here, keeping in mind that apart from a
2 times enrichment in sequences, negative effects of highly
expressed antisense products is circumvented as well. Such
improvements might than make prefractionation of mRNA
unnecessary if the gene of interest is constitutively expressed.
Prefractionation of mRNA and libraries of higher complexity
might still be necessary if genes which are expressed only at very
low level are to be isolated.
During the last decades a large number of human biochemically
mutant cell strains have been collected. Of special interest are
cell lines which are hypersensitive to environmental agents, as
selection for a corrected phenotype can be easily performed in
cell culture. Unfortunately, the isolation of the genes involved
has been hampered by the poor transfectability of human cell
lines. We believe that episomal cDNA expression vectors
constitute a new efficient tool which might greatly simplify the
isolation of these human genes*.
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* During the preparation of this manuscript Hasyakawa and coworkers (1) succeeded
in the isolation of the cDNA coding for 0 -methylguanine methyltransferase,
making use of an EBV-derived vector system and by directly correcting the
deficiency of a human cell line. Their system however was far from perfect due
to the presence of the EBNA-1 gene on a separate plasmid, which resulted in
the integration of the cDNA of interest.
